SCHEMBL4237270

SCHEMBL4237270

Cc1ccccc1-n1c(CCCNc2ncnc3c2ncn3C2CCCCO2)nc2ccsc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ CYP1A2 P05177 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.38
▸ ABL1 P00519 2/20 0.36
▸ RIN1 Q13671 2/20 0.36
▸ YTHDC1 Q96MU7 1/20 0.36
▸ FLT3 P36888 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ADORA3 P0DMS8 2/20 0.35
▸ ADORA2A P29274 2/20 0.35
▸ PIK3R1 P27986 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ CCNA2 P20248 1/20 0.35
▸ CDK2 P24941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4228491 0.90 NPC1 (0.53) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4227217 0.89 SMN1; SMN2 (0.46) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4237005 0.88 NPC1 (0.46) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4233647 0.86 NPC1 (0.45) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4227286 0.86 NPC1 (0.46) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL1703780 0.83 NPC1 (0.45) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4229018 0.82 SMN1; SMN2 (0.42) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4239144 0.81 PIK3CD (0.42) PIK3CDCYP1A2HPGDCYP2C19TSHR
SCHEMBL936036 0.77 NPC1 (0.52) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL1703383 0.75 NPC1 (0.49) PIK3CDNPC1RAB9ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097422-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS Eli Lilly & Co. (US) 2009-09-09 — — EP disclosed
WO-2008064018-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS ELI LILLY & CO. (US) 2008-05-29 — — WO disclosed
Send feedback